BVI & BIAH Strengthen Strategic Partnership – A Bold Step Toward a Sustainable Future in Animal Health
We’re excited to share a significant milestone in Botswana’s journey toward sustainable animal health and agricultural excellence.
Since its inception in 1978, the Botswana Vaccine Institute (BVI) has stood at the forefront of livestock health, playing a critical role in the control of Foot and Mouth Disease (FMD) and contributing to the country’s renowned beef export industry.
On 31st January 2025, BVI officially renewed its strategic partnership with Boehringer Ingelheim Animal Health (BIAH), a collaboration that began during the 1978 FMD outbreak and was first established with MERIAL, a company later acquired by BIAH.
During the signing ceremony, Acting Minister of Agriculture, Hon. Dr. Edwin Dikoloti, stated:
“This collaboration has transformed BVI into a world-class laboratory, producing a range of vaccines using cutting-edge technologies and meeting rigorous international standards.”
Key Benefits of the Renewed Partnership:
- Product Diversification: Enhancing BVI’s portfolio for sustainable growth.
- Regional Expansion: Strengthening Botswana’s position in the global animal health landscape.
- Innovation Hub: Establishing a state-of-the-art Research & Development Centre.
- Skills Transfer: Empowering local professionals through knowledge exchange and capacity building.
This renewed commitment not only deepens the collaboration between BVI and BIAH but also reflects a shared vision for innovation, resilience, and long-term economic empowerment.
As we move forward, this partnership promises to elevate Botswana’s leadership in animal health and biotechnology across the region and beyond.
Together, we are building a healthier, more sustainable future for livestock and for the nation.









